Zygomycosis in Italy: A survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology)

Journal of Chemotherapy

Volumn 21, Issue 3, 2009, Pages 322-329

  Pagano, Livio ^a   Valentini, C G ^a   Posteraro, B ^a   Girmenia, C ^b   Ossi, C ^c   Pan, A ^d   Candoni, A ^e   Nosari, A ^f   Riva, M ^f   Cattaneo, C ^d   Rossini, F ^g   Fianchi, L ^a   Caira, M ^a   Sanguinetti, M ^a   Gesu, G P ^f   Lombardi, G ^f   Vianelli, N ^h   Stanzani, M ^h   Mirone, E ^h   Pinsi, G ⁱ   Facchetti, F ⁱ   Manca, N ⁱ   Savi, L ^a   Mettimano, M ^a   Selva, V ^j   Caserta, I ^j   Scarpellini, P ^c   Morace, G ^k   D'Arminio Monforte, A ^k   Grossi, P ^l   Giudici, D ^c   Tortorano, A M ^k   Bonini, A ^m   Ricci, L ^m   Picardi, M ⁿ   Rossano, F ⁿ   Fanci, R ^o   Pecile, P ^o   Fumagalli, L ^c   Ferrari, L ^c,y   Capecchi, P L ^p   Romano, C ^p   Busca, A ^q   Barbui, A ^q   Garzia, M ^r   Minniti, R R ^r   Farina, G ^s   Montagna, M T ^t   Bruno, F ^t   Morelli, O ^f   Chierichini, A ^u   Placanica, P M ^u   Castagnola, E ^v   Bandettini, R ^v   Giordano, S ^w   Monastero, R ^w   Tosti, M E ^x   Rossi, M R ^k   Spedini, P ^y   Piane, R ^p   Nucci, M ^c   Pallavicini, F ^a   Bassetti, M ^z   Cristini, F ^e   La Sorda, M ^a   Viviani, M ^k   more..

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d SPEDALI CIVILI   (Italy)

^e UNIVERSITY OF UDINE   (Italy)

^f OSPEDALE NIGUARDA CA GRANDA   (Italy)

^g SAN GERARDO HOSPITAL   (Italy)

^h UNIVERSITY OF BOLOGNA   (Italy)

ⁱ UNIVERSITY OF BRESCIA   (Italy)

^j Ospedale S Anna e San Sebastiano   (Italy)

^k UNIVERSITY OF MILAN   (Italy)

^l UNIVERSITY OF INSUBRIA   (Italy)

^m S MARIA NUOVA HOSPITAL   (Italy)

ⁿ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^o UNIVERSITY OF FLORENCE   (Italy)

^p UNIVERSITY OF SIENA   (Italy)

^q UNIVERSITY OF TURIN   (Italy)

^r SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^s CATHOLIC UNIVERSITY   (Italy)

^t UNIVERSITY OF BARI   (Italy)

^u SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^v G GASLINI INSTITUTE   (Italy)

^w UNIVERSITY OF PALERMO   (Italy)

^x ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^y CREMONA HOSPITAL   (Italy)

^z UNIVERSITY OF GENOA   (Italy)

more..

Author keywords

Epidemiology; Immunocompromised host; Zygomycosis

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; CONTROLLED STUDY; DEBRIDEMENT; DIAGNOSTIC PROCEDURE; FEMALE; HEALTH SURVEY; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOCOMPROMISED PATIENT; ITALY; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORTALITY; MUCORMYCOSIS; NEUTROPENIA; PARANASAL SINUS DISEASE; PENETRATING TRAUMA; PREVALENCE; PROGNOSIS; SEX DIFFERENCE; SKIN INFECTION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 68349117117     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2009.21.3.322     Document Type: Article

References (24)

1. Rinaldi GM. Zygomycosis. Infect Dis Clin North Am 1989; 3: 19-41.
2. Eucker J, Sezer O, Graf B, Possinger K. Mucormycoses. Mycoses 2001; 44(7-8): 253-260
3. Petrikkos G, Skiada A, Sambatakou H, Toskas A, Vaiopoulos G, Giannopoulou M, et al. Zygomycosis: ten-year experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis 2003; 12:753-756
4. Sugar AM. Zygomycosis. Clin Infect Dis 1992; 14(Suppl 1): 126-129
5. Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, et al. Zygomycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. Br J Haem 1997; 99: 331-336 (Pubitemid 27497563)
6. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000; 30:851-856
7. Pagano L, Offidani M, Fianchi L, Nosari A, Candoni A, Piccardi M, et al. Zygomycosis in hematologic patients. Haematologica. 2004; 89(2):207-214
8. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46(12):1813-1821.
9. Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria. Clin Infect Dis 2008; 47: 674-683
10. StataCorp. 2003. Stata Statistical Software: Release 8.1. College Station, TX: Stata Corporation.
11. Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 2007; 45(4):321-346 (Pubitemid 46839802)
12. Rickerts V, Bohme A, Just-Nubling G. Risk factor for invasive zygomycosis in patients with hematologic malignancies. Mycoses 2002; 45(Suppl 1):27-30. (Pubitemid 34886355)
13. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41(5):634-653
14. Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 2005;191(8):1350-1360 (Pubitemid 40503665)
15. Morrison VA, McGlave PB. Zygomycosis in the BMT population. Bone Marrow Transpl 1993; 11: 383-388
16. Nosari A, Oreste P, Montillo M, Carrafiello G, Draisci M, Muti G, et al. Zygomycosis in hematologic malignancies: an emerging fungal infection. Haematologica 2000; 85: 1068-1071 (Pubitemid 30831940)
17. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34:909-917 (Pubitemid 34229758)
18. Gupta T, Sachdev N, Kaur J, Dey P, Gupta V, Gupta A. Endogenous mycotic endophthalmitis in an immunocompetent patient. Int Ophthalmol 2008.
19. Tehmeena W, Hussain W, Zargar HR, Sheikh AR, Iqbal S. Primary cutaneous mucormycosis in an immunocompetent host. Mycopathologia 2007;164(4):197-199 (Pubitemid 47397479)
20. Jain D, Kumar Y, Vasishta RK, Rajesh L, Pattari SK, Chakrabarti A. Zygomycotic necrotizing fasciitis in immunocompetent patients: a series of 18 cases. Mod Pathol 2006;19(9):1221-1226 (Pubitemid 44268192)
21. Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003; 51: 45-52.
22. Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 2008;47(4):503-509
23. Pfaller MA, Messer SA, Hollis RJ, Jones RN; SENTRY Participants Group. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob Agents Chemother 2002; 46:1032-1037
24. Greenberg RN, Mullane K, Van Burik JA, Raad I, Abzug MJ, Anstead G, et al. Posaconazole as savage therapy for zygomicosis. Antimicrob Chemother 2006; 50(1):126-133